Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient

30 Mar 2024 //

FIERCE PHARMA

Accused of complicity in opioid crisis, Teva launches nasal spray

25 Dec 2021 //

TIMESOFISRAEL

Teva`s Ajovy can`t find solid win against oral migraine rivals

09 Sep 2021 //

FIERCEPHARMA

Teva Announces Analysis of Long-Term Data Examining Treatment with AUSTEDO®

20 Aug 2021 //

BUSINESSWIRE

AbbVie`s oral migraine treatment atogepant nears FDA decision

20 Aug 2021 //

FIERCEBIOTECH

Teva Wins Appeal That Upholds Three Patents for Migraine Drug

17 Aug 2021 //

BLOOMBERGLAW

Teva Piles Onto Strong-Arm Tactic Accusations Against DOJ

06 Aug 2021 //

LAW360

Federal circuit upholds Teva-GlaxoSmithKline decision

06 Aug 2021 //

ENDPTS

Mylan claims Teva blocked the entry of generic Copaxone rivals

02 Jul 2021 //

FIERCEPHARMA

NY jury urged to hold drugmakers liable for US opioid crisis

01 Jul 2021 //

REUTERS

Teva reaches $925K settlement in generic price-fixing case

24 Jun 2021 //

FIERCEPHARMA

TRISENOX (arsenic trioxide) - Important Safety Information from Teva Pharma

06 Nov 2020 //

HPRA

Novartis CEO says Malaria drug is biggest hope against coronavirus - SonntagsZeitung

30 Mar 2020 //

ECONOMIC TIMES

Teva`s Ajovy scores backing from England`s cost watchdogs

13 Mar 2020 //

FIERCE PHARMA

Perrigo launches generic version of Teva`s ProAir

26 Feb 2020 //

GLOBES

Teva must return non-MS Copaxone rights to Proneuron

16 Jan 2020 //

GLOBES

Eurolife Healthcare acquires intravenous infusion business of Teva, Hungary

25 Dec 2019 //

ECONOMIC TIMES

Can Botox hang with CGRP in migraine? Allergan says yes

15 Jan 2019 //

FIERCE PHARMA

JPM recap: Must-reads of the week, from FDA to IPO to M&A

12 Jan 2019 //

FIERCE PHARMA

Novartis abandons effort for U.S. approval of rituximab

03 Nov 2018 //

REUTERS

Pharma Sector May Lose $65 Bn by 2019: Analyst

10 Dec 2014 //

BIOSPECTRUMASIA

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass